Ischemia Reperfusion Injury Clinical Trial
Official title:
Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
Does caffeine reduce rosuvastatin induced protection against ischemia reperfusion injury?
Rosuvastatin is a proven cholesterol lowering medicine, which hereby is assumed to achieve a reduction in cardiovascular events. Apart from it's cholesterol lowering action, rosuvastatin may also increase tolerance against ischemia-reperfusion injury. In dogs rosuvastatin increases the endogenous concentration of adenosine, by enhancing the activity of the enzyme ecto-5'-nucleotidase, which converts adenosine monophosphate into adenosine. We hypothesize that rosuvastatin increases tolerance against ischemia-reperfusion injury by induction of ecto-5'-nucleotidase and thereby increasing adenosine activity. This protective effect of rosuvastatin can be abrogated by using the adenosine receptor antagonist caffeine. ;
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06369350 -
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
|
Early Phase 1 | |
| Withdrawn |
NCT04388761 -
Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)
|
Phase 1 | |
| Completed |
NCT00987974 -
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
|
Phase 4 | |
| Recruiting |
NCT04750616 -
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
|
Phase 2 | |
| Recruiting |
NCT05992259 -
Auricular Vagus Stimulation and STEMI
|
N/A | |
| Completed |
NCT04493983 -
Role of Oxidative Stress in Ovarian Tissue After CO2-pneumoperitoneum Application-induced I/R
|
N/A | |
| Completed |
NCT03510793 -
Microcirculation and Anesthesia in Vascular Surgery
|
||
| Recruiting |
NCT02845154 -
Intermittent Portal and Graft Purge in Living Donor Liver Transplantation
|
N/A | |
| Terminated |
NCT01564095 -
TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion
|
Phase 2/Phase 3 | |
| Completed |
NCT03482544 -
The Effect of Pregabalin Given Preoperatively on the Tourniquet Induced Ischemia-reperfusion
|
Phase 4 | |
| Not yet recruiting |
NCT05004610 -
Hypertonic Lactate After Cardiac Arrest
|
Phase 2 | |
| Completed |
NCT04205253 -
Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue
|
||
| Completed |
NCT03410576 -
Perioperative Time Course of MMP-9 and Its Inhibitor During Carotid Artery Stenting and Carotid Endarterectomy
|
N/A | |
| Completed |
NCT03743584 -
Hypothermia After Cardiac Arrest - Effects on Myocardial Function and Inflammatory Response.
|
N/A | |
| Recruiting |
NCT04005469 -
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04630535 -
OSA as a Remote Ischemic Preconditioning in Vascular Surgery
|
||
| Completed |
NCT01610401 -
The Metformin-FMD Trial
|
Phase 4 | |
| Active, not recruiting |
NCT00876902 -
YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation
|
Phase 2 | |
| Completed |
NCT03541239 -
Immune Modulation by Ischemic Pre-conditioning in Healthy Individuals: Intracellular Signalling in Regulatory Cells
|
N/A | |
| Recruiting |
NCT05430620 -
Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
|
Phase 3 |